Also: semi-sodium valproate,
valproate, valproic acid, valproate semisodium
U.S. Preparations:
Depakote® ER
(Abbott Laboratories) FDA approved:
8.4.2000 for the prophylaxis of migraine headaches in adults
8.14.2003 as monotherapy and adjunctive therapy in the treatment of adults and
children 10 years of age or older with complex partial seizures that occur
either in isolation or in association with other types of seizures, sole and
adjunctive therapy in the treatment of simple and complex absence seizures in
adults and children 10 years of age or older, and adjunctively in adults and
children 10 years of age or older with multiple seizure types that include
absence seizures
12.06.2005 for the treatment of acute
manic or mixed episodes associated
with bipolar disorder, with or without
psychotic features
| Dose: |
125 mg. |
| Color: |
gray |
| Shape: |
ovaloid |
| Type: |
tablet |
| Imprint: |
Abbott logo
Abbo-Code HF |
Depakote®
(Abbott Laboratories) FDA approved:
3.10.1983 for treatment of epilepsy
3.18.1994 prevention of migraine
5.26.1995 mania
| Dose: |
125 mg. |
250 mg. |
500 mg. |
| Color: |
salmon pink |
peach |
lavender |
| Shape: |
oval |
oval |
oval |
| Type: |
tablet |
tablet |
tablet |
| Imprint: |
Abbot logo |
Abbot logo |
Abbot logo |
Depakote® Sprinkle (Abbott Laboratories) FDA approved:
9.12.1989 for treatment of epilepsy
3.18.1994 prevention of migraine
5.26.1995 mania
| Dose: |
125 mg. |
| Color: |
blue/clear |
| Shape: |
oval |
| Type: |
capsule |
| Imprint: |
Depakote
Sprinkle
125 mg |
Preparations Outside U.S.:
- Epival, Everiden, Novoseven, Valcote
|
